Amennai Beyeen
Analyst-Equity en Rhenman & Partners Asset Management AB .
Perfil
Dr. Amennai Beyeen is an Analyst at Rhenman & Partners Asset Management AB.
He has15 years of experience in medical positions within the life science industry.
Dr. Beyeen was previously employed as a Principal by Novartis Pharma (Sweeden) and a Principal by GlaxoSmithKline AB.
He received his graduate degree from Karolinska Institutet and a doctorate degree from Karolinska Institutet.
Cargos activos de Amennai Beyeen
Empresas | Cargo | Inicio |
---|---|---|
Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Analyst-Equity | 01/04/2023 |
Antiguos cargos conocidos de Amennai Beyeen.
Empresas | Cargo | Fin |
---|---|---|
Novartis Pharma (Sweeden) | Corporate Officer/Principal | 01/04/2023 |
GlaxoSmithkline AB
GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AB is a Swedish pharmaceutical company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01/07/2005 |
Formación de Amennai Beyeen.
Karolinska Institutet | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Finance |
GlaxoSmithkline AB
GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AB is a Swedish pharmaceutical company that manufactures pharmaceutical products. | Health Technology |
Novartis Pharma (Sweeden) |
- Bolsa de valores
- Insiders
- Amennai Beyeen